Review
Rev Diabet Stud,
2011,
8(1):6-16 |
DOI 10.1900/RDS.2011.8.6 |
2011 Update on Pancreas Transplantation: Comprehensive Trend Analysis of 25,000 Cases Followed Up Over the Course of Twenty-Four Years at the International Pancreas Transplant Registry (IPTR)
Angelika C. Gruessner
Division of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin, Tucson AZ 85724, USA
Manuscript submitted April 11, 2011; resubmitted April 19, 2011; accepted May 11, 2011.
Keywords: diabetes, pancreas transplantation, mortality, donor factors, surgical techniques, immunosuppressive protocols, UNOS
Abstract
AIM: This study aimed to analyze the outcome of pancreas and pancreas-kidney transplantations based on the comprehensive follow-up data reported to the International Pancreas Transplant Registry (IPTR). METHODS: As of December 2010, more than 35,000 pancreas transplantations have been reported to the IPTR: more than 24,000 transplantations in the US and more than 12,000 outside the US. Cases with follow-up information until March 2011 were included in the analysis. RESULTS: Pancreas transplantations in diabetic patients were divided into 3 categories: those performed simultaneously with a kidney (SPK) (75%), those given after a previous kidney transplantation (PAK) (18%), and pancreas transplantation alone (PTA) (7%). The total number of pancreas transplantations steadily increased until 2004 but has since declined. The largest decrease was seen in PAK, which decreased by 50% from 2004 through 2010. Comparatively, the number of SPK decreased by 7% during this time. Era analysis of US transplantations between 1987 and 2010 showed changes in recipient and donor characteristics. Recipient age at transplantation increased significantly as well as transplantations in type 2 diabetes patients. The trend over time was towards tighter donor criteria. There was a concentration on younger donors, preferable trauma victims, with short preservation time. Surgical techniques for the drainage of the pancreatic duct changed over time, too. Now enteric drainage is the predominantly used technique in combination with systemic drainage of the venous effluent of the pancreas graft. Immunosuppressive protocols developed towards antibody induction therapy with tacrolimus and MMF as maintenance therapy. The rate of transplantations with steroid avoidance increased over time in all 3 categories. These changes have led to improved patient and graft survival. Patient survival now reaches over 95% at one year post-transplant and over 83% after 5 years. The best graft survival was found in SPK with 86% pancreas and 93% kidney graft function at one year. PAK pancreas graft function reached 80%, and PTA pancreas graft function reached 78% at one year. In all 3 categories, early technical graft loss rates decreased significantly to 8-9%. Likewise, the 1-year immunological graft loss rate also decreased: in SPK, the immunological 1-year graft loss rate was 1.8%, in PAK 3.7%, and in PTA 6.0%. CONCLUSIONS: Patient survival and graft function improved significantly over the course of 24 years of pancreas transplantation in all 3 categories. With further reduction in surgical complications and improvements in immunosuppressive protocols, pancreas transplantation offers excellent outcomes for patients with labile diabetes.
Fulltext:
HTML
, PDF
(521KB)
This article has been cited by other articles:
|
Duodenal Leaks after Pancreas Transplantation with Enteric Drainage - Characteristics and Risk Factors
Spetzler VN, Goldaracena N, Marquez MA, Singh SK, Norgate A, McGilvray ID, Schiff J, Greig PD, Cattral MS, Selzner M
Transpl Int 2015. In press
|
|
|
Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges-but offers improved endoscopic access for scheduled biopsies and therapeutic interventions
Horneland R, Paulsen V, Lindahl JP, Grzyb K, Eide TJ, Lundin K, Aabakken L, Jenssen T, Aandahl EM, Foss A, Oyen O
Am J Transplant 2015. 15(1):242-250
|
|
|
Simultaneous pancreas and kidney transplantation: current trends and future directions
Redfield RR, Scalea JR, Odorico JS
Curr Opin Organ Transplant 2015. 20(1):94-102
|
|
|
Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation
Reine TM, Kolseth IB, Meen AJ, Lindahl JP, Jenssen TG, Reinholt FP, Zaia J, Shao C, Hartmann A, Kolset SO
Diabetes Res Clin Pract 2015. 107(1):46-53
|
|
|
Late pancreas retransplantation
Fridell JA, Mangus RS, Chen JM, Goble ML, Mujtaba MA, Taber TE, Powelson JA
Clin Transplant 2015. 29(1):1-8
|
|
|
Health-related quality of life may improve after transplantation in pancreas-kidney recipients
Martins S, Outerelo C, Malheiro J, Fonseca IM, Henriques AC, Dias LS, Rodrigues AS, Cabrita AM, Noronha IL
Clin Transplant 2015. In press
|
|
|
Intensive therapy after solid organ transplantation
Mayer K, Müller M, Schmidt J, Weigand MA
Intensivmedizin 2015. 2015:1219-1243
|
|
|
Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC
Expert Opin Biol Ther 2014. 14(12):1723-1730
|
|
|
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Oyen O, Brabrand K, Jenssen T
Diabetologia 2014. 57(11):2357-2365
|
|
|
Type 2 diabetes: is pancreas transplantation an option?
Ciancio G, Burke GW
Curr Diab Rep 2014. 14(11):542
|
|
|
Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions
Rangel EB
Expert Opin Drug Metab Toxicol 2014. 10(11):1585-1605
|
|
|
Crucial role for neuronal nitric oxide synthase in early microcirculatory derangement and recipient survival following murine pancreas transplantation
Cardini B, Watschinger K, Hermann M, Obrist P, Oberhuber R, Brandacher G, Chuaiphichai S, Channon KM, Pratschke J, Maglione M, Werner ER
Plos One 2014. 9(11):e112570
|
|
|
Improving monitoring after pancreas transplantation alone: fine-tuning of an old technique
Voskuil MD, Mittal S, Sharples EJ, Vaidya A, Gilbert J, Friend PJ, Ploeg RJ
Clin Transplant 2014. 28(9):1047-1053
|
|
|
Case report: pancreas graft with a duodenal complication rescued using total duodenectomy
Uva PD, Villavicencio Fornaciari S, Giunippero AE, Cabrera IC, Casadei DH
Transplant Proc 2014. 46(9):3068-3071
|
|
|
Islet xenotransplantation: what is the optimal age of the islet-source pig?
Nagaraju S, Bottino R, Wijkstrom M, Trucco M, Cooper DK
Xenotransplantation 2014. In press
|
|
|
125 Cases of duodenoduodenostomy in pancreas transplantation: a single-centre experience of an alternative enteric drainage
Walter M, Jazra M, Kykalos S, Kuehn P, Michalski S, Klein T, Wunsch A, Viebahn R, Schenker P
Transpl Int 2014. 27(8):805-815
|
|
|
Multivariate analysis of complications after simultaneous pancreas and kidney transplantation
Grochowiecki T, Gałazka Z, Madej K, Frunze S, Nazarewski S, Jakimowicz T, Paczek L, Durlik M, Szmidt J
Transplant Proc 2014. 46(8):2806-2809
|
|
|
The use of venous jump grafts in pancreatic transplantation - no difference in patient or allograft outcomes - an update of the UNOS database
Siskind E, Maloney C, Ashburn S, Akerman M, Siskind T, Goldberg L, Bhaskaran M, Basu A, Molmenti E, Ortiz J
Clin Transplant 2014. 28(8):883-888
|
|
|
Type 1 diabetes through the life span: a position statement of the American Diabetes Association
Chiang JL, Kirkman MS, Laffel LM, Peters AL, Type 1 Diabetes Sourcebook Authors
Diabetes Care 2014. 37(7):2034-2054
|
|
|
Pancreas transplantation
Knight S, Vogel T, Friend P
Surgery (Oxford) 2014. 32(7):383-388
|
|
|
Design of bioartificial pancreas with functional micro/nano-based encapsulation of islets
Kepsutlu B, Nazli C, Bal T, Kizilel S
Curr Pharm Biotechnol 2014. 15(7):590-608
|
|
|
Has the gap between pancreas and islet transplantation closed?
Niclauss N, Morel P, Berney T
Transplantation 2014. 98(6):593-599
|
|
|
High urine amylase level and the risk of enteric conversion in solitary pancreas transplant recipients
Kukla A, Radosevich DM, Finger EB, Kandaswamy R
Transplant Proc 2014. 46(6):1938-1941
|
|
|
Excellent outcomes can be achieved in young pancreas transplant alone recipients by addition of sirolimus to maintenance immunosuppression regimen
Porubsky M, Gruessner AC, Rana A, Jie T, Gruessner RW
Transplant Proc 2014. 46(6):1932-1935
|
|
|
5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC
Transplant Proc 2014. 46(6):1928-1931
|
|
|
Similar results with solitary pancreas transplantation compared with simultaneous pancreas-kidney transplantation in the new millennium
Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Rogers J
Transplant Proc 2014. 46(6):1924-1927
|
|
|
Evaluation of insulin independence using 11C-methionine positron emission tomography after living-donor and brain-dead donor pancreas transplantation
Otsuki K, Yoshikawa K, Kenmoshi T, Akutsu N, Maruyama M, Asano T, Saigo K, Hasegawa M, Aoyama H, Matsumoto I, Ito T, Uchino Y
Transplant Proc 2014. 46(6):1913-1916
|
|
|
Simultaneous pancreas-kidney transplantation with duodeno-duodenal anastomosis
Khubutia M, Pinchuk A, Dmitriev I, Storozhev R
Transplant Proc 2014. 46(6):1905-1909
|
|
|
Risk factors of pancreatic graft loss and death of receptor after simultaneous pancreas/kidney transplantation
Sousa MG, Linhares MM, Salzedas-Netto AA, Gonzalez AM, Rangel EB, Sa JR, Araujo SG, Melaragno CS, Lopes-Filho G, Medina Pestana OJ
Transplant Proc 2014. 46(6):1827-1835
|
|
|
Multi detector computed tomography (MDCT) for the diagnosis of early complications after pancreas transplantation
Vincent M, Morla O, Branchereau J, Karam G, Dupas B, Frampas E
Abdom Imaging 2014. 39(6):1186-1192
|
|
|
Recent advances in pancreatic transplantation
Iacovidou A, Hakim N
Exp Clin Transplant 2013. 11(6):471-474
|
|
|
Why is organ transplantation clinically important?
Grinyo JM
Cold Spring Harb Perspect Med 2013. 3(6):a014985
|
|
|
Management of brittle diabetes
Darias-Garzon R, Garcia-Bray BF, Gomez-Alvarez B
Acances Diabetol 2014. 30(6):167-172
|
|
|
Pancreas transplantation: The Wake Forest experience in the new millennium
Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ
World J Diabetes 2014. 5(6):951-961
|
|
|
Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients
Falconer SJ, Jansen C, Oniscu GC
Transplant Proc 2014. 46(5):1458-1462
|
|
|
Long-term Effects of Delayed Graft Function on Pancreas Graft Survival After Pancreas Transplantation
Shin S, Han DJ, Kim YH, Han S, Choi BH, Jung JH, Cho HK
Transplantation 2014. In press
|
|
|
Is there a role for surgery in the treatment of type 2 diabetes?
Benedix F, Meyer F, Klose S, Stroh C, Lippert H
Dtsch Med Wochenschr 2014. 139(5):207-212
|
|
|
Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?
Martins LS, Henriques AC, Fonseca IM, Rodrigues AS, Oliverira JC, Dores JM, Dias LS, Cabrita AM, Silva JD, Noronha IL
Clin Transplant 2014. 28(4):462-469
|
|
|
Intercellular adhesion molecular-1, Fas, and Fas ligand as diagnostic biomarkers for acute allograft rejection of pancreaticoduodenal transplantation in pigs
Dong GH, Li XF, Li JZ, Zhang ZD, Hu WM, Luo YH, Li ZD, Tian BL, He MX, Zhu XW
Dig Dis Sci 2014. 59(4):778-786
|
|
|
Pancreas transplantation in type II diabetes mellitus
Weems P, Cooper M
World J Transplant 2014. 4(4):216-221
|
|
|
Imaging in pancreatic transplants
Heller MT, Bhargava P
Indian J Radiol Imaging 2014. 24(4):339-349
|
|
|
Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention
Little SA, Leelarathna L, Barendse SM, Walkinshaw E, Tan HK, Lubina Solomon A, de Zoysa N, Rogers H, Choudhary P, Amiel SA, Heller SR, Evans M, Flanagan D, Speight J, Shaw JA
Diabetes Metab Res Rev 2014. 30(3):175-190
|
|
|
Endovascular treatment of pancreatic allograft transplant arteriovenous fistula using amplatzer vascular plug 2
Abdel-Aal AK, Elsayed A, Saddekni S, Hamed MF, Young C
Cardiovasc Intervent Radiol 2014. 37(3):819-824
|
|
|
Liver, pancreas and small bowel transplantation: current ethical issues
van Dijk G, Hilhorst M, Rings E
Best Pract Res Clin Gastroenterol 2014. 28(2):281-292
|
|
|
Experience with 53 portal-duodenal drained solitary pancreas transplants
Perosa M, Noujaim H, Ianhez LE, Oliveira RA, Mota LT, Branez JR, Paredes MM, Giacaglia L, Genzini T
Clin Transplant 2014. 28(2):198-204
|
|
|
Overcoming barriers in clinical islet transplantation: current limitations and future prospects
Chhabra P, Sutherland DE, Brayman KL
Curr Probl Surg 2014. 51(2):49-86
|
|
|
Transplant options for patients with type 2 diabetes and chronic kidney disease
Fourtounas C
World J Transplant 2014. 4(2):102-110
|
|
|
Stem Cell-Derived Beta Cells for Treatment of Type 1 Diabetes?
Goland R, Egli D
Ebio Med 2014. 1(2-3):93-94
|
|
|
Long-term outcomes after organ transplantation in diabetic end-stage renal disease
Lindahl JP, Jenssen T, Hartmann A
Diabetes Res Clin Pract 2014. 105(1):14-21
|
|
|
Therapeutic cell encapsulation techniques and applications in diabetes.
Steele JA, Halle JP, Poncelet D, Neufeld RJ
Adv Drug Deliv Rev 2014. 67-68:74-83
|
|
|
Long-term survival after simultaneous pancreas-kidney transplantation with primary function of at least one year - a single-center experience
Schulz T, Pries A, Caliebe A, Kapischke M
Ann Transplant 2014. 19:106-111
|
|
|
Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution
Scharp DW, Marchetti P
Adv Drug Deliv Rev 2014. 67-68:35-73
|
|
|
Pancreas transplantation with portal venous drainage with an emphasis on technical aspects
Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ
Clin Transplant 2014. 28(1):16-26
|
|
|
Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective
Stratta RJ, Farney AC, Rogers J, Orlando G
Expert Rev Clin Immunol 2014. 10(1):117-132
|
|
|
Islet and stem cell encapsulation for clinical transplantation
Krishnan R, Alexander M, Robles L, Foster CE 3rd, Lakey JR
Rev Diabet Stud 2014. 11(1):84-101
|
|
|
Banff classification for pancreas transplantation
Kenmochi T
Japan J Transplant 2014. 49(1):30-34
|
|
|
Pancreas Transplantation in African American Compared to Non African American Patients: Does Recipient Ethnicity Influence Outcomes?
Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Rogers J
Diabetes Pancreas 2014. 1(1):1-8
|
|
|
Pancreas Transplantation with Systemic-Enteric Drainage when Portal-Enteric Drainage is Contraindicated
Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, El-Hennawy H, Rogers J
Pancreat Disord Ther 2014. 4:2
|
|
|
Life after pancreas transplantation: reversal of diabetic lesions
Dunn TB
Curr Opin Organ Transplant 2014. 19(1):73-79
|
|
|
Pancreas Transplantation of Non-Traditional Recipients
Sayed BA, Turgeon NA
Curr Transplant Rep 2014. 1(1):113-118
|
|
|
Simultaneous kidney and pancreas transplantation in patients with type 1 diabetes mellitus at Clinica Fundacion Valle del Lily, Cali, Colombia
Serrano OJ, Villegas JI, Echeverri GJ, Posada JG, Mesa L, Schweineberg J, Duran C, Caicedo LA
Rev Colomb Cir 2014. 29:32-41
|
|
|
Death Receptor in the First Year after Simultaneous Pancreas/Kidney
Transplantation
Sousa MG, Linhares MM, Salzedas A, Gonzalez AM, Rangel E, Sa JR, Melaragno C, Cezar LD, Lopes-Filho GJ, Pestana JO
J Nephrol Ther 2014. 4:1
|
|
|
Perspective of simultaneous pancreas-kidney transplantation
Schenker P, Viebahn R
Dtsch Med Wochenschr 2013. 138(18):958-963
|
|
|
Pancreas transplantation: a single-institution experience in Japan
Okabe Y, Kitada H, Miura Y, Nishiki T, Kurihara K, Kawanami S, Terasaka S, Kaku K, Noguchi H, Sugitani A, Tanaka M
Surg Today 2013. 43(12):1406-1411
|
|
|
Clinically significant peripancreatic fluid collections after simultaneous pancreas-kidney transplantation
Singh RP, Vrakas G, Hayek S, Hayek S, Anam S, Aqueel M, Olsburgh J, Calder F, Mamode N, Callaghan C, Kessaris N, Pattison J, Hilton R, Koffman G, Taylor JD, Drage MW
Transplantation 2013. 95(10):1263-1269
|
|
|
Examination of carbohydrate metabolism parameters after simultaneous pancreas-kidney transplantation
Földes K, Piros L, Toronyi E, Wagner L, Chmel R, Török S, Nagy K, Ghimessy A, Brinzanek D, Pocze B, Langer RM, Gero L
Transplant Proc 2013. 45(10):3698-3702
|
|
|
Pancreas graft survival in simultaneous pancreas-kidney versus pancreas-after-kidney and pancreas alone transplantations: a single institution experience
Montiel-Casado MC, Perez-Daga JA, Aranda-Narvaez JM, Fernandez-Burgos I, Sanchez-Perez B, Leon-Diaz FJ, Cabello-Diaz M, Rodriguez-Burgos D, Hernandez-Marrero D, Santoyo-Santoyo J
Transplant Proc 2013. 45(10):3609-3611
|
|
|
Combined pancreas-kidney transplantation for patients with end-stage nephropathy caused by type-2 diabetes mellitus
Margreiter C, Resch T, Oberhuber R, Aigner F, Maier H, Sucher R, Schneeberger S, Ulmer H, Bösmüller C, Margreiter R, Pratschke J, Öllinger R
Transplantation 2013. 95(8):1030-1036
|
|
|
Induction therapy in pancreas transplantation
Niederhaus SV, Kaufman DB, Odorico JS
Transpl Int 2013. 26(7):704-714
|
|
|
A composite risk model for predicting technical failure in pancreas transplantation
Finger EB, Radosevich DM, Dunn TB, Chinnakotla S, Sutherland DE, Matas AJ, Pruett TL, Kandaswamy R
Am J Transplant 2013. 13(7):1840-1849
|
|
|
Sonographic evaluation of abdominal transplants: A practical approach
Shum DJ, Kim T, Poder L
Appl Radiol 2013. 42(7):8-18
|
|
|
Imaging pancreas transplants
Yates A, Parry C, Stephens M, Eynon A
Br J Radiol 2013. 86(1030):20130428
|
|
|
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T
Diabetologia 2013. 56(6):1364-1371
|
|
|
Islet xenotransplantation from genetically engineered pigs
Nagaraju S, Bottino R, Wijkstrom M, Hara H, Trucco M, Cooper DK
Curr Opin Organ Transplant 2013. 18(6):695-702
|
|
|
Insulin replacement therapy in patients with type 1 diabetes by isolated pancreatic islet transplantation
Poradzka A, Wronski J, Jasik M, Karnafel W, Fiedor P
Acta Pol Pharm 2013. 70(6):943-950
|
|
|
Beyond islet transplantation in diabetes cell therapy: from embryonic stem cells to transdifferentiation of adult cells
Gioviale MC, Bellavia M, Damiano G, Lo Monte AI
Transplant Proc 2013. 45(5):2019-2024
|
|
|
Type 1 diabetes: pancreas and islet transplantation
Wardle J, Philips A
Pract Nursing 2013. 24(5):243-246
|
|
|
What would surgeons like from materials scientists?
Grundfest-Broniatowski S
Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013. 5(4):299-319
|
|
|
Pancreas transplantation, antibodies and rejection: where do we stand?
de Kort H, Roufosse C, Bajema IM, Drachenberg CB
Curr Opin Organ Transplant 2013. 18(3):337-344
|
|
|
Pancreas-kidney transplantation: analysis of 150 patients from one centre in Portugal
Martins LS, Fonseca I, Aguiar P, Rocha A, Costa R, Santos C, Malheiro J, Pedroso S, Almeida M, Dias L, Henriques AC, Cabrita A, Davide J
Port J Nephrol Hypert 2013. 27(3):173-178
|
|
|
Trauma after transplant: hold the antibiotics please
Tessier JM, Sirkin M, Wolfe LG, Duane TM
Surg Infect (Larchmt) 2013. 14(2):177-180
|
|
|
Immunosuppressive therapy for pancreas and islet transplantation
Maruyama M, Kenmochi T, Ito T, Akutsu N, Asano T
Organ Biol 2013. 20(2):218-221
|
|
|
Follow-up of secondary diabetic complications after pancreas transplantation
Boggi U, Rosati CM, Marchetti P
Curr Opin Organ Transplant 2013. 18(1):102-110
|
|
|
Donor risk factors, retrieval technique, preservation and ischemia/reperfusion injury in pancreas transplantation
Maglione M, Ploeg RJ, Friend PJ
Curr Opin Organ Transplant 2013. 18(1):83-88
|
|
|
Trends in immunosuppression after pancreas transplantation: what is in the pipeline?
Kimelman M, Brandacher G
Curr Opin Organ Transplant 2013. 18(1):76-82
|
|
|
Immunological monitoring after pancreas transplantation
Margreiter C, Pratschke J, Margreiter R
Curr Opin Organ Transplant 2013. 18(1):71-75
|
|
|
Arteriojejunal Fistula Presenting with Recurrent Obscure GI Hemorrhage in a Patient with a Failed Pancreas Allograft
Desai N, Patel S, Nwosu C, Sung L, Tack C, Buscaglia JM, Nord EP, Wadhwa NK
Case Rep Transplant 2013. 2013:171807
|
|
|
Kidney, Pancreas and Islet Transplant Options for Patients with Diabetic Nephropathy
Fourtounas C, Dousdampanis P
Diabetes Metab 2013. 2013:S9
|
|
|
Technical Aspects of Pancreas Transplantation with Portal Venous Drainage
Farooq U, Al-Shraideh Y, Rogers J, Farney AC, Orlando G, Stratta RJ
Pancreatic Dis Ther 2013. 3:2
|
|
|
Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome
Shapiro AM
Rev Diabet Stud 2012. 9(4):385-406
|
|
|
The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation
Rangel EB
Expert Opin Drug Metab Toxicol 2012. 8(12):1531-1548
|
|
|
T cell autoreactivity in the transplant milieu
Matthis J, Nepom GT
Am J Transplant 2012. 12(7):1674-1681
|
|
|
Evolution of pancreas transplantation: long-term results and perspectives from a high-volume center
Ollinger R, Margreiter C, Bösmüller C, Weissenbacher A, Frank F, Schneeberger S, Mark W, Margreiter R, Pratschke J
Ann Surg 2012. 256(5):780-786
|
|
|
Diabetes treatment in 2025: can scientific advances keep pace with prevalence?
Shomali M
Ther Adv Endocrinol Metab 2012. 3(5):163-173
|
|
|
Pancreas transplantation
Chaillous L
Med Malad Metabol 2012. 6(5):389-395
|
|
|
Imaging of miscellaneous pancreatic pathology (trauma, transplant, infections, and deposition)
Holalkere NS, Soto J
Radiol Clin North Am 2012. 50(3):515-528
|
|
|
Curing diabetes with transplantation?
Richter A, Lerner SM, Schröppel B
Mt Sinai J Med 2012. 79(2):267-275
|
|
|
Portal venous versus systemic venous drainage of pancreas grafts: impact on long-term results
Bazerbachi F, Selzner M, Marquez MA, Norgate A, Aslani N, McGilvray ID, Schiff J, Cattral MS
Am J Transplant 2012. 12(1):226-232
|
|
|
Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention
Farney AC, Rogers J, Stratta RJ
Curr Opin Organ Transplant 2012. 17(1):87-92
|
|
|
Long-term outcome after pancreas transplantation
Gruessner AC, Sutherland DE, Gruessner RW
Curr Opin Organ Transplant 2012. 17(1):100-105
|
|
|
Progress in abdominal organ transplantation
Kosieradzki M, Lisik W, Rowinski W, Malkowski P
Med Sci Monit 2011. 17(12):RA282-RA291
|
|
|
Cell therapy in type 1 diabetes
Gioviale MC, Bellavia M, Damiano G, Buscemi G
J Stem Cell Res Ther 2011. S2:4
|
|
|
Type 1 diabetes mellitus: beyond the insulin therapy
Fodor A, Cozma A
Clujul Med 2011. 84(4):499-503
|
|
|
Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients
Boggi U, Vistoli F, Amorese G, Giannarelli R, Coppelli A, Mariotti R, Rondinini L, Barsotti M, Piaggesi A, Tedeschi A, Signori S, De Lio N, Occhipinti M, Mangione E, Cantarovich D, Del Prato S, Mosca F, Marchetti P
Rev Diabet Stud 2011. 8(2):259-267
|
|
|
The IKEM Pancreas and Islet Transplant Program as Part of Healthcare for Type 1 Diabetes Patients: Retrospective Analysis of Outcome from 1983 to 2010
Girman P, Saudek F
Rev Diabet Stud 2011. 8(1):35-43
|
|
|